Viewing nowLefren Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

MFDS item code 201109229 · Approved 2011.10.27 · Insurance code 621802550
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial seizures in epilepsy
This medication is used to treat peripheral and central neuropathic pain in adults, and is also used as an adjunct for partial seizures in patients with epilepsy. It is effective in alleviating symptoms of fibromyalgia. It is used to improve various neurological and pain-related diseases.
Administer this medicine orally as pregabalin in 2 divided doses per day, with or without food. This medicine is primarily excreted by the kidneys; therefore, the dose should be adjusted in patients with impaired renal function (see section 5, “Patients with renal impairment”). 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The starting dose is 150 mg/day. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may thereafter be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central neuropathic pain Adults: The starting dose is 150 mg/day. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered (see section 4, “Discontinuation”). 2. Epilepsy Adults: The starting dose is 150 mg/day. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may thereafter be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg to 450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, it may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies were also conducted at a dose of 600 mg/day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over at least 1 week. 5. Patients with renal impairment Dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an immediate supplemental dose should be given after each 4-hour hemodialysis session. Creatinine clearance (CLcr) ≥60: Starting dose 150 mg/day, maximum dose 600 mg/day, BID or TID Creatinine clearance (CLcr) ≥30 -<60: Starting dose 75 mg/day, maximum dose 300 mg/day, BID or TID Creatinine clearance (CLcr) ≥15 -<30: Starting dose 25-50 mg/day, maximum dose 150 mg/day, QD or BID Creatinine clearance (CLcr) <15: Starting dose 25 mg/day, maximum dose 75 mg/day, QD Supplemental dose after hemodialysis: 25 mg, 100 mg, single dose TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as specified under the dosing regimen. b: Supplemental dose refers to an additional dose given once. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (65 years and older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 ~17 years: Administration is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts and behaviors; therefore, it is important to closely monitor for symptoms of depression, mood changes, or abnormal behavioral changes during treatment. Patients who are allergic to pregabalin or any ingredient in this medication, or those with genetic lactose intolerance, should not take this medication. Diabetes patients should be cautious, as weight gain may necessitate dose adjustments of blood sugar control medications. If serious allergic reactions such as angioedema occur, discontinue the medication immediately and consult a healthcare provider. Elderly patients may experience increased dizziness or drowsiness; caution should be exercised when starting the medication. This medication may temporarily cause visual disturbances such as blurred vision, so patients should inform healthcare providers of any changes in vision. Stopping the medication suddenly may result in withdrawal symptoms such as insomnia, headache, and anxiety, so it should be discontinued gradually according to a doctor's instructions. Due to the risk of drug abuse, patients with a history of substance misuse should be particularly cautious, and watch for signs of misuse or dependency. Patients with impaired renal function should have their dosages adjusted, and those with severe heart disease should take this medication cautiously. Caution is advised when combining with other medications that have a central nervous system depressant effect or opioids, as there is a risk of respiratory depression. Pregnant women should avoid this medication during early pregnancy due to potential risks of fetal malformations, and women of childbearing potential should use effective contraception while on this medication. Breastfeeding women should discuss with their doctors, as this medication may be passed into breast milk and affect the infant, possibly necessitating discontinuation of breastfeeding or the medication. There is a risk of accidents due to dizziness or drowsiness when driving or operating machinery, so caution must be taken if these symptoms occur during initial treatment. This medication can cause serious skin reactions, so if symptoms such as a rash, swelling, or fever occur, discontinue use immediately and inform a healthcare provider. In the event of overdose, symptoms such as confusion, drowsiness, and seizures may occur; strict adherence to the prescribed dosage is important, and in case of overdose, seek emergency medical assistance immediately. Store this medication out of reach of children and do not transfer it to another container to maintain its quality.
Suicidal impulses, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, perioral swelling, upper respiratory tract swelling, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, sadness, suicidal thoughts, pain, seizures, hyperhidrosis, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, rhinitis, neutropenia, increased appetite, decreased appetite, hypoglycemia, confusion, spatial disorientation, irritability, euphoria, decreased libido, depersonalization, dysesthesias, agitation, mood instability, emotional decline, emotional elevation, difficulty finding appropriate terms, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, apathy, ataxia, abnormal motor coordination, balance disorders, amnesia, attention deficit, memory impairment, tremors, dysarthria, sensory disturbances, decreased sensation, sedation, drowsiness, cognitive impairment, nystagmus, speech disorders, muscular spasms, decreased reflexes, motor abnormalities, psychomotor agitation, positional dizziness, hyperesthesia, burning sensation, action tremors, syncope, stupor, hypokinesia, olfactory abnormalities, taste loss, writing difficulties, blurred vision, diplopia, visual field loss, field defects, photophobia, dry eyes, eye swelling, decreased vision, ocular pain, eye fatigue, increased tear secretion, ocular irritation, mydriasis, during vibration, changes in depth perception, strabismus, brightness of vision, dizziness, hyperacusis, 1st-degree heart block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, excessive salivation, gastroesophageal reflux disease, oral sensory impairment, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweats, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle twitching, neck pain, muscle stiffness, rhabdomyolysis, urinary disorders, urinary incontinence, reduced urine output, kidney failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, breast pain, breast discharge, breast enlargement, peripheral edema, edema, gait abnormalities, falls, feeling drunk, altered sensation, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased creatine phosphokinase in the blood, increased aspartate aminotransferase, increased blood sugar, decreased platelet count, decreased potassium in the blood, weight loss, increased creatinine in the blood, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, pulmonary edema, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis (facial paralysis), mood disorder, drowsiness, confusional state, agitation, restlessness, seizures
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly sealed container to protect it from air and moisture, and it is best stored in a cool place between 15 and 30 degrees Celsius. Storing it this way helps maintain its effectiveness over time.
Hard capsule with upper part reddish-brown and lower part white
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.